Table 3.
A. Determined by Kappa statistic | ||||
---|---|---|---|---|
Kappa calculation | n (pair)a | Average n (profile)b | Mean | Bootstrapped mean (95% CI)c |
Severity | ||||
Between rheumatologists and pulmonologists | 66 | 7.6 | 0.13 | 0.13 (0.00, 0.25) |
Among rheumatologists | 44 | 8.7 | 0.17 | 0.17 (−0.01, 0.45) |
Among pulmonologists | 17 | 6.6 | 0.20 | 0.18 (0, 0.25) |
Risk of progression | ||||
Between rheumatologists and pulmonologists | 66 | 6.6 | 0.61 | 0.59 (0.49, 0.69) |
Among rheumatologists | 44 | 8.3 | 0.70 | 0.66 (0.51, 0.86) |
Among pulmonologists | 17 | 5.9 | 0.48 | 0.4618 (0.26, 0.66) |
Progression | ||||
Between rheumatologists and pulmonologists | 66 | 3.1 | 0.56 | 0.51 (0.18, 0.70) |
Among rheumatologists | 44 | 3.5 | 0.78 | 0.70 (0.36, 0.95) |
Among pulmonologists | 17 | 3.1 | 0.29 | 0.24 (−0.00, 0.50) |
B. Determined by χ2 analysis | |||
---|---|---|---|
χ2 calculation | Rheumatology | Pulmonology | P-value |
Severityd | |||
Clinical ILD | 205 (93.2%) | 114 (89.8%) | 0.26 |
Subclinical ILD | 15 (6.8%) | 13 (10.2%) | |
Risk of progression | |||
High risk | 97 (45.3%) | 55 (46.2%) | 0.88 |
Low risk | 117 (54.7%) | 64 (53.8%) | |
Progression | |||
Progressive | 17 (18.9%) | 11 (20.0%) | 0.20 |
Stable | 57 (63.3%) | 40 (72.7%) | |
Improved | 16 (17.8%) | 4 (7.3%) |
Number of paired used to calculate kappa statistics.
Average number of profile in each pair.
100 bootstrap datasets, randomly selecting based on profile with replacement.
‘Cannot tell’ was removed from this calculation.